Clinical Trial Update: Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis. [Phase 3]

View source ↗

Summary

A Phase 3 multicenter trial comparing allogeneic and autologous mesenchymal cells against hyaluronic acid for knee osteoarthritis is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Allogeneic mesenchymal cells (mesenchymal stem cells (allogeneic))
• Autologous mesenchymal cells (mesenchymal stem cells (autologous))
• Hyaluronic acid (hyaluronic acid)

Snippet

Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | Conditions: Knee Osteoarthritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING